Improving Sexual Function in Postmenopausal Women

After menopause, some women are distressed about their inability to enjoy sex or their avoidance of intimate acts because they know it will be painful, thanks to a loss of estrogen and its effect on vulvar and vaginal tissues. Ospemifene has been approved for the treatment of dyspareunia, or painful sex, in postmenopausal women. But what kind of effect does it have on hormone levels, and how much relief does this treatment really offer?

In this video, David Portman, MD, of the Columbus Center for Women's Health Research, Columbus, Ohio, discusses what he's learned through new research on the drug and how it relates to improvement in sexual function in postmenopausal women.

This research was presented last month at the 25th Annual Meeting of The North American Menopause Society.